Wms Partners Continues to Hold Stake in Pfizer (PFE); Linscomb & Williams Has Decreased Its Position in General Electric Co (GE) as Share Price Declined

Pfizer Inc. (NYSE:PFE) Logo

Wms Partners Llc increased its stake in Pfizer Inc (PFE) by 125.28% based on its latest 2018Q3 regulatory filing with the SEC. Wms Partners Llc bought 31,321 shares as the company’s stock rose 5.56% while stock markets declined. The hedge fund held 56,321 shares of the health care company at the end of 2018Q3, valued at $2.48M, up from 25,000 at the end of the previous reported quarter. Wms Partners Llc who had been investing in Pfizer Inc for a number of months, seems to be bullish on the $240.81 billion market cap company. The stock decreased 0.50% or $0.21 during the last trading session, reaching $41.66. About 12.97M shares traded. Pfizer Inc. (NYSE:PFE) has risen 25.07% since February 13, 2018 and is uptrending. It has outperformed by 25.07% the S&P500. Some Historical PFE News: 15/05/2018 – Rexahn Pharm: SMC Confirmed Combination of RX-3117 and Abraxane Is Safe and Well Tolerated; 23/03/2018 – GSK pullout puts sale of Pfizer consumer health unit in doubt; 20/03/2018 – Roche’s Tecentriq with Chemotherapy Phase III IMpower131 Study Met Co-Primary Endpoint; 15/05/2018 – FDA- APPROVAL OF RETACRIT FOR TREATMENT OF ANEMIA CAUSED BY CHRONIC KIDNEY DISEASE, CHEMOTHERAPY, OR USE OF ZIDOVUDINE IN PATIENTS WITH HIV INFECTION; 16/03/2018 – Ian Read, BTW, has been at $PFE for 40 years — and they wanted a noncompete; 08/05/2018 – XTALPI REPORTS STRATEGIC RESEARCH PACT WITH PFIZER TO DEVELOP; 16/05/2018 – Pfizer: Compounds Represent Potential Oncology Advancements in Lung, Breast, Hematologic, Prostate Cancers; 17/04/2018 – Blood-cancer treatments Imbruvica and Darzalex have boosted J&J’s pharmaceutical sales, while rheumatoid arthritis drug Remicade has been under pressure; 10/04/2018 – PFIZER: DATA MONITORING COMMITTEE RECOMMENDED STOPPING TRIAL; 03/04/2018 – PFIZER IN TALKS WITH P&G ON CONSUMER BUSINESS SALE – CNBC, CITING

Linscomb & Williams Inc decreased its stake in General Electric Co (GE) by 68.34% based on its latest 2018Q3 regulatory filing with the SEC. Linscomb & Williams Inc sold 196,020 shares as the company’s stock declined 44.60% with the market. The institutional investor held 90,815 shares of the consumer electronics and appliances company at the end of 2018Q3, valued at $1.03 million, down from 286,835 at the end of the previous reported quarter. Linscomb & Williams Inc who had been investing in General Electric Co for a number of months, seems to be less bullish one the $89.29 billion market cap company. The stock increased 2.86% or $0.29 during the last trading session, reaching $10.27. About 65.64M shares traded. General Electric Company (NYSE:GE) has declined 60.87% since February 13, 2018 and is downtrending. It has underperformed by 60.87% the S&P500. Some Historical GE News: 21/03/2018 – GE Additive Donates 3D Metal Printer to the University of Cincinnati; 12/04/2018 – Market-beating value investor Bill Nygren is long Facebook, GE; 21/05/2018 – ELECNOR SA ENOR.MC SAYS IN CONSORTIUM WITH GENERAL ELECTRIC WINS CONTRACT FOR CONSTRUCTION OF 100 MW WIND FARM IN JORDAN; 11/04/2018 – FBO:Veteran Aff: Veterans Affairs Contract Award – Y–603-CSI-802 – D/B PET/CT PH2 -GE Equipment Installation – Robley Rex VA; 14/03/2018 – Exclusive – GE EFS said to launch loan portfolio sale; 27/03/2018 – ENERGA TO BACK GE-ALSTOM BID FOR OSTROLEKA POWER PROJECT; 19/04/2018 – Commentary: General Electric is the only earnings report that matters right now, via @TradingNation; 21/05/2018 – WABTEC – DEAL WITH GE IS EXPECTED TO GENERATE ABOUT $150M OF ANNUAL CASH TAX SAVINGS FOR NEXT 15 YEARS; 21/05/2018 – GE agrees $11bn transport tie-up; 17/04/2018 – ITALY’S GOVERNMENT SAYS HAS DECIDED TO USE SPECIAL POWERS ON LICENCE GIVEN BY AVIO SPA AND GE AVIO TO ARIANEGROUP FOR THE DEVELOPMENT OF AEROSPACE MATERIAL

Among 23 analysts covering Pfizer (NYSE:PFE), 9 have Buy rating, 1 Sell and 13 Hold. Therefore 39% are positive. Pfizer had 92 analyst reports since July 29, 2015 according to SRatingsIntel. The rating was upgraded by Suntrust Robinson to “Neutral” on Wednesday, November 25. The stock of Pfizer Inc. (NYSE:PFE) earned “Buy” rating by Jefferies on Tuesday, June 14. The firm has “Hold” rating given on Friday, April 13 by Jefferies. The rating was maintained by Morgan Stanley on Friday, April 7 with “Neutral”. The firm earned “Buy” rating on Friday, August 14 by Piper Jaffray. The stock has “Buy” rating by Jefferies on Tuesday, September 13. As per Friday, October 2, the company rating was upgraded by Morgan Stanley. Barclays Capital maintained Pfizer Inc. (NYSE:PFE) rating on Thursday, August 23. Barclays Capital has “Equal-Weight” rating and $40 target. The company was upgraded on Thursday, January 31 by Argus Research. Morgan Stanley maintained Pfizer Inc. (NYSE:PFE) on Wednesday, January 31 with “Overweight” rating.

Investors sentiment increased to 0.85 in 2018 Q3. Its up 0.07, from 0.78 in 2018Q2. It improved, as 41 investors sold PFE shares while 741 reduced holdings. 142 funds opened positions while 520 raised stakes. 3.96 billion shares or 0.44% less from 3.98 billion shares in 2018Q2 were reported. 340,200 are owned by Barometer Cap Management Inc. Benin Management has 15,975 shares. Sfe Invest Counsel owns 0.66% invested in Pfizer Inc. (NYSE:PFE) for 38,991 shares. Eagle Global Advsrs Limited Co has 16,209 shares for 0.02% of their portfolio. Cullen Capital Management invested in 2.85% or 1.75 million shares. Atria Ltd Liability Corp invested in 0.37% or 210,967 shares. Rock Point Ltd Liability Corporation holds 0.38% in Pfizer Inc. (NYSE:PFE) or 19,166 shares. Roof Eidam & Maycock Adv holds 1.12% or 56,505 shares in its portfolio. Moreover, Wesbanco Bank & Trust has 0.74% invested in Pfizer Inc. (NYSE:PFE). Bainco International invested 0.04% in Pfizer Inc. (NYSE:PFE). Plante Moran Fin Advisors Ltd Llc reported 26,616 shares stake. Pettee Investors, Connecticut-based fund reported 147,623 shares. Eubel Brady And Suttman Asset Mgmt Inc reported 6,312 shares. Moreover, Rand Wealth Limited Liability has 1.06% invested in Pfizer Inc. (NYSE:PFE). Thompson Siegel Walmsley Ltd invested 0.18% in Pfizer Inc. (NYSE:PFE).

Since January 30, 2019, it had 0 buys, and 1 sale for $1.81 million activity.

More notable recent Pfizer Inc. (NYSE:PFE) news were published by: Streetinsider.com which released: “EMD Seron, Pfizer (PFE) Announce FDA Accepted sBLA and Granted Priority Review for BAVENCIO Plus INLYTA for Treatment of Advanced RCC – StreetInsider.com” on February 11, 2019, also Seekingalpha.com with their article: “Pfizer Biopharmaceuticals Group’s Late-Stage Pipeline Looks Well Positioned – Seeking Alpha” published on February 06, 2019, Seekingalpha.com published: “Pfizer Looks To Move Tafamidis Forward With Priority Review – Seeking Alpha” on January 22, 2019. More interesting news about Pfizer Inc. (NYSE:PFE) were released by: Streetinsider.com and their article: “Pfizer (PFE) Tops Q4 EPS by 1c, FY EPS Guidance Misses Consensus – StreetInsider.com” published on January 29, 2019 as well as Streetinsider.com‘s news article titled: “Pfizer Inc. (NYSE: PFE) and Astellas Announce Phase 3 ARCHES Trial Shows XTANDI Significantly Improved Radiographic PFS in Men with Metastatic Hormone-Sensitive Prostate Cancer – StreetInsider.com” with publication date: February 11, 2019.

Wms Partners Llc, which manages about $2.55 billion and $890.61M US Long portfolio, decreased its stake in Vanguard Index Fds (VTI) by 5,487 shares to 756,484 shares, valued at $113.21M in 2018Q3, according to the filing. It also reduced its holding in Centurylink Inc (NYSE:CTL) by 18,500 shares in the quarter, leaving it with 14,684 shares, and cut its stake in Weingarten Rlty Invs (NYSE:WRI).

Investors sentiment decreased to 0.56 in Q3 2018. Its down 0.03, from 0.59 in 2018Q2. It fall, as 83 investors sold GE shares while 743 reduced holdings. 114 funds opened positions while 346 raised stakes. 4.54 billion shares or 0.56% more from 4.51 billion shares in 2018Q2 were reported. 222,108 are held by Oarsman. Timber Creek Management Limited Liability Corp holds 5,105 shares. Autus Asset Mngmt Ltd owns 0.02% invested in General Electric Company (NYSE:GE) for 11,111 shares. Woodstock has invested 0.6% in General Electric Company (NYSE:GE). Boston Family Office Lc stated it has 0.19% in General Electric Company (NYSE:GE). Parametric Portfolio Associates Ltd holds 0.18% in General Electric Company (NYSE:GE) or 17.75M shares. Wms Ptnrs Lc invested in 95,669 shares. Cambridge Inc holds 0.07% or 19,037 shares. Associated Banc holds 303,635 shares. Park Oh holds 1.41M shares. Fil holds 3.94 million shares. Guggenheim Ltd Liability holds 0.07% in General Electric Company (NYSE:GE) or 954,026 shares. Culbertson A N & Com holds 0.19% or 60,140 shares in its portfolio. Stellar Llc has 103,505 shares. At Comml Bank invested 0.12% in General Electric Company (NYSE:GE).

Since November 1, 2018, it had 3 insider buys, and 0 sales for $2.78 million activity. DIMITRIEF ALEXANDER bought $94,800 worth of stock or 10,000 shares. Another trade for 60,000 shares valued at $499,200 was made by DSOUZA FRANCISCO on Wednesday, November 14.

Among 30 analysts covering General Electric Company (NYSE:GE), 13 have Buy rating, 3 Sell and 14 Hold. Therefore 43% are positive. General Electric Company had 125 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was maintained by Vertical Research on Tuesday, January 16 with “Hold”. Cowen & Co initiated it with “Market Perform” rating and $29 target in Tuesday, June 7 report. The firm earned “Outperform” rating on Tuesday, October 2 by Wolfe Research. S&P Research maintained the shares of GE in report on Monday, August 17 with “Buy” rating. The rating was upgraded by Bernstein to “Outperform” on Friday, December 16. Barclays Capital maintained it with “Overweight” rating and $13 target in Wednesday, October 31 report. The rating was upgraded by Barclays Capital to “Overweight” on Monday, October 8. Stifel Nicolaus maintained General Electric Company (NYSE:GE) on Tuesday, January 30 with “Hold” rating. As per Thursday, January 4, the company rating was maintained by Tigress Financial. The stock of General Electric Company (NYSE:GE) has “Hold” rating given on Sunday, December 10 by Stifel Nicolaus.

More notable recent General Electric Company (NYSE:GE) news were published by: Seekingalpha.com which released: “General Electric: Thoughts On The ‘Reworked’ Wabtec Deal – Seeking Alpha” on January 28, 2019, also Prnewswire.com with their article: “GE CLASS ACTION ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against General Electric Company – GE – PRNewswire” published on February 13, 2019, Seekingalpha.com published: “General Electric: A Significant Recalibration – Seeking Alpha” on January 26, 2019. More interesting news about General Electric Company (NYSE:GE) were released by: Benzinga.com and their article: “What’s Next For GE? Two Pros Debate (NYSE:GE) – Benzinga” published on January 16, 2019 as well as Globenewswire.com‘s news article titled: “CLASS ACTION UPDATE for ARLO, DXC, GSM and GE: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders – GlobeNewswire” with publication date: February 13, 2019.

Pfizer Inc. (NYSE:PFE) Institutional Positions Chart